Published in Cancer Control on July 01, 2005
In vitro screening for the tumoricidal properties of international medicinal herbs. Phytother Res (2009) 0.99
Complementary and alternative medicine: use and disclosure in radiation oncology community practice. Support Care Cancer (2010) 0.98
The Public Health Impact of Herbs and Nutritional Supplements. Pharm Biol (2009) 0.90
Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers. Support Care Cancer (2008) 0.84
Bioactive tanshinone I inhibits the growth of lung cancer in part via downregulation of Aurora A function. Mol Carcinog (2012) 0.82
Identification of a novel Calotropis procera protein that can suppress tumor growth in breast cancer through the suppression of NF-κB pathway. PLoS One (2012) 0.81
Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo. J Exp Clin Cancer Res (2015) 0.80
Evaluation and implications of natural product use in preoperative patients: a retrospective review. BMC Complement Altern Med (2009) 0.78
LC-MS/MS Identification of a Bromelain Peptide Biomarker from Ananas comosus Merr. Evid Based Complement Alternat Med (2012) 0.77
In vitro screening of tumoricidal properties of international medicinal herbs: part II. Phytother Res (2010) 0.76
HERBAL PRODUCT USE BY THE CANCER PATIENTS IN BOTH THE PRE AND POST SURGERY PERIODS AND DURING CHEMOTHERAPY. Afr J Tradit Complement Altern Med (2017) 0.75
Pinning down vulnerability: from narratives to numbers. Disasters (2010) 1.56
The specific role of isoflavones in reducing prostate cancer risk. Prostate (2004) 1.16
The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer (2002) 1.07
A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer. Nutr Cancer (2007) 0.99
Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy. Clin Med Urol (2008) 0.99
Safety of purified isoflavones in men with clinically localized prostate cancer. Nutr Cancer (2007) 0.86
Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy. J Soc Integr Oncol (2010) 0.84
A case-control study evaluating the association of purposeful physical activity, body fat distribution, and steroid hormones on premenopausal breast cancer risk. Breast J (2005) 0.82
Evaluation of surveillance methods for detection of West Nile virus activity in East Baton Rouge Parish, Louisiana, 2004-2006. J Am Mosq Control Assoc (2009) 0.80
Use of complementary/integrative nutritional therapies during cancer treatment: implications in clinical practice. Cancer Control (2002) 0.77
Determining the quantity and character of carotid artery embolic debris by electron microscopy and energy dispersive spectroscopy. J Vasc Surg (2007) 0.77